Heteronemin as a Protein Farnesyl Transferase Inhibitor

Author： Ledroit Véronique   Debitus Cécile   Ausseil Frédéric   Raux Roselyne   Menou Jean-Louis   Hill Bridget  

Publisher： Informa Healthcare

ISSN： 1388-0209

Source： Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol.42, Iss.6, 2004-09, pp. : 454-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesyl Protein Transferase Inhibitor ZARNESTRA™ R115777 - History of a Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1095-1102

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyl Protein Transferase Inhibition: A Novel Approach to Anti-tumor

By  

Current Medicinal Chemistry, Vol. 8, Iss. 12, 2001-10 ,pp. : 1419-1436

Bentham Science Publishers

Access to resources Recommend Favorite

Tipifarnib, a farnesyl transferase inhibitor, appears to have potential for patients with locally advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

By Macdonald John   McCoy Sheryl   Whitehead Robert   Iqbal Syma   Wade James   Giguere Jeffrey   Abbruzzese James  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 485-487

Springer Publishing Company

Access to resources Recommend Favorite

Farnesyl transferase inhibitors in clinical development

By Caponigro Francesco   Casale Marina   Bryce Jane  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 943-954

Informa Healthcare

Access to resources Recommend Favorite